|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From the Department of Biology, Hong Kong University of Science and Technology, Queen Mary Hospital, University of Hong Kong, Hong Kong
2 From the Department of Pathology, Queen Mary Hospital, University of Hong Kong, Hong Kong
Lung resections from 50 Chinese patients in Hong Kong diagnosed as having non-small cell lung carcinoma were examined for the presence of mutations in the p53 gene by polymerase chain reaction single-stranded conformation polymorphism methods and for aberrant protein expression by immunostaining techniques. Eight-point mutations in the evolutionarily conserved exon 5 through 8 regions were detected. Abnormal expression of p53 detectable by immunostaining techniques was seen in 23 specimens tested. There was no statistically significant correlation between the detection of p53 aberrations and age, sex, smoking history, histologic type, and tumor stage. Aberrant p53 protein levels detectable by immunostaining were significantly associated with the clinical and nodal staging of the tumors.
Key Words: Hong Kong lung carcinoma p53
Submitted on May 24, 1995
Accepted on September 25, 2007
This article has been cited by other articles:
![]() |
E. C. Chan, S. Y. Lam, K. W. Tsang, B. Lam, J. C. M. Ho, K. H. Fu, W. K. Lam, and Y. L. Kwong Aberrant Promoter Methylation in Chinese Patients with Non-Small Cell Lung Cancer: Patterns in Primary Tumors and Potential Diagnostic Application in Bronchoalevolar Lavage Clin. Cancer Res., December 1, 2002; 8(12): 3741 - 3746. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Paschke Reply to the contribution of Hainaut, Olivier and Pfeifer (TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database) Mutagenesis, November 1, 2001; 16(6): 555 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Lam, W K Lam, C L Lam, G C Ooi, J C M Ho, M P Wong, and K W Tsang Adenocarcinoma of the lung in Chinese patients: a revisit and some perspectives from the literature Postgrad. Med. J., November 1, 2001; 77(913): 708 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hainaut and G. P. Pfeifer Patterns of p53 G{->}T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke Carcinogenesis, March 1, 2001; 22(3): 367 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Tammemagi, J. R. McLaughlin, and S. B. Bull Meta-Analyses of p53 Tumor Suppressor Gene Alterations and Clinicopathological Features in Resected Lung Cancers Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 625 - 634. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |